Serum creatine kinase activity differentiates alcohol syndromes of dependence, withdrawal and delirium tremens
暂无分享,去创建一个
Abraham Weizman | Avi Avital | Michael Segal | Abraham Weizman | M. Segal | Alla Rusakov | Sergio Sandbank | A. Avital | A. Rusakov | Sergio Sandbank
[1] H. Hermesh,et al. Recurrence pattern of serum creatine phosphokinase levels in repeated acute psychosis , 1998, Biological Psychiatry.
[2] Peter M Nalin,et al. Nontraumatic rhabdomyolysis with long-term alcohol intoxication. , 2004, The Journal of the American Board of Family Practice.
[3] S. Kapur,et al. Role of the dopaminergic system in depression , 1992, Biological Psychiatry.
[4] Y. Mizuno,et al. Serum creatine kinase is elevated in patients with Parkinson's disease: a case controlled study. , 2003, Parkinsonism & related disorders.
[5] R. Roberts,et al. Expression of brain‐type creatine kinase and ubiquitous mitochondrial creatine kinase in the fetal rat brain: Evidence for a nuclear energy shuttle , 1995, The Journal of comparative neurology.
[6] P. Ritchie. Neuroleptic malignant syndrome , 1983 .
[7] H. Meltzer. Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message? , 2000, Psychopharmacology.
[8] M. Crawford,et al. Evaluation of CK and CK-MB in alcohol abuse subjects with recent heavy consumption. , 1995, Cardiology.
[9] F. Bloom,et al. Cellular and molecular mechanisms of drug dependence. , 1988, Science.
[10] M. Wiener,et al. Creatine kinase activity decrease with short-term freezing. , 1994, Enzyme & protein.
[11] R. Hemmingsen,et al. Delirium tremens and related clilnical states:| Psychopathology, cerebral pathophysiology and psychochemistry: A two‐component hypothesis concerning etiology and pathogenesis , 1988, Acta psychiatrica Scandinavica. Supplementum.
[12] A. Pérez-Bouza,et al. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue , 2005, Neuroscience.
[13] H. Meltzer,et al. Mean serum creatine kinase activity in patients with functional psychoses. , 1980, Archives of general psychiatry.
[14] M A Schuckit,et al. Genetic and clinical implications of alcoholism and affective disorder. , 1986, The American journal of psychiatry.
[15] H. Kranzler,et al. Persistent delirium following cessation of heavy alcohol consumption: diagnostic and treatment implications. , 1997, The American journal of psychiatry.
[16] A. Lawrence,et al. The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[17] R. Hemmingsen,et al. Delirium tremens; SOME CLINICAL FEATURES. PART I , 1979, Acta psychiatrica Scandinavica.
[18] G. Gessa,et al. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. , 1992, European journal of pharmacology.
[19] U. Ungerstedt,et al. Neurochemical Correlates of Cocaine and Ethanol Self‐Administration a , 1992, Annals of the New York Academy of Sciences.
[20] H. Ikeda. Serum Creatine Phosphokinase Activity in Newly Admitted Chronic Alcoholics , 1977, Folia psychiatrica et neurologica japonica.
[21] Dennis S. Charney,et al. Neuropsychopharmacology : The Fifth Generation of Progress , 2002 .
[22] T. Miura,et al. Inactivation of creatine kinase induced by dopa and dopamine in the presence of ferrylmyoglobin. , 1999, Chemico-biological interactions.
[23] Y. Benjamini,et al. Serum creatine kinase levels in untreated hospitalized adolescents during acute psychosis. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.
[24] Abraham Weizman,et al. Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients , 2007, European Neuropsychopharmacology.
[25] P. Janicak,et al. Drug treatment of the neuroleptic malignant syndrome. , 1991, Psychopharmacology bulletin.
[26] J. Mann,et al. Lower CSF Homovanillic Acid Levels in Depressed Patients with a History of Alcoholism , 2003, Neuropsychopharmacology.
[27] A. Lança,et al. Reduction of voluntary alcohol intake in the rat by modulation of the dopaminergic mesolimbic system: Transplantation of ventral mesencephalic cell suspensions , 1994, Neuroscience.
[28] Y. Benjamini,et al. High Serum Creatinine Kinase Level: Possible Risk Factor for Neuroleptic Malignant Syndrome , 2002, Journal of clinical psychopharmacology.
[29] Abraham Weizman,et al. CK levels in unmedicated bipolar patients , 2007, European Neuropsychopharmacology.
[30] R. Christopher Pierce,et al. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants , 1997, Brain Research Reviews.
[31] A. Cools,et al. Creatine kinase B‐driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility , 2002, The European journal of neuroscience.
[32] S. Hyman,et al. Neural mechanisms of addiction: the role of reward-related learning and memory. , 2006, Annual review of neuroscience.
[33] F Weiss,et al. Ethanol Self-Administration Restores Withdrawal-Associated Deficiencies in Accumbal Dopamine and 5-Hydroxytryptamine Release in Dependent Rats , 1996, The Journal of Neuroscience.
[34] L. Chiodo,et al. Acute withdrawal after repeated ethanol treatment reduces the number of spontaneously active dopaminergic neurons in the ventral tegmental area , 1993, Brain Research.
[35] B. Rounsaville,et al. Psychopathology as a predictor of treatment outcome in alcoholics. , 1987, Archives of general psychiatry.
[36] C. Nemeroff,et al. 72 MOLECULAR AND CELLULAR MECHANISMS IN DEPRESSION , 2002 .
[37] R. Hemmingsen,et al. Delirium tremens: SOME CLINICAL FEATURES. PART II , 1979, Acta psychiatrica Scandinavica.
[38] R. Shen. Ethanol Withdrawal Reduces the Number of Spontaneously Active Ventral Tegmental Area Dopamine Neurons in Conscious Animals , 2003, Journal of Pharmacology and Experimental Therapeutics.
[39] Abraham Weizman,et al. Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome , 2000, Acta psychiatrica Scandinavica.
[40] M. Pistis,et al. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[41] R. Kessler,et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.
[42] G. Koob,et al. Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis , 1998, Neuropsychopharmacology.
[43] D. Ciraulo. Neuropsychopharmacology: The Fifth Generation of Progress , 2003 .